We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+10.11%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$47.1B
AUM Growth
+$2.61B
Cap. Flow
-$501M
Cap. Flow %
-1.06%
Top 10 Hldgs %
14.43%
Holding
3,576
New
705
Increased
706
Reduced
825
Closed
988

Top Buys

Rank Stock Value
1
WMT icon
Walmart Inc
WMT
+$417M
2
META icon
Meta Platforms (Facebook)
META
+$383M
3
AMZN icon
Amazon
AMZN
+$308M
4
MSFT icon
Microsoft
MSFT
+$293M
5
GE icon
GE Aerospace
GE
+$263M

Top Sells

Rank Stock Value
1
CI icon
Cigna
CI
+$312M
2
BAC icon
Bank of America
BAC
+$292M
3
XOM icon
ExxonMobil
XOM
+$274M
4
LULU icon
lululemon athletica
LULU
+$238M
5
QCOM icon
Qualcomm
QCOM
+$228M

Sector Composition

Rank Sector Weight
1 Healthcare 17.05%
2 Technology 14.35%
3 Consumer Discretionary 13.97%
4 Financials 9.9%
5 Industrials 6.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ATSG
1376
DELISTED
Air Transport Services Group
ATSG
$2.21M ﹤0.01%
106,188
+55,800
+111% +$1.35M
ROIV icon
1377
Roivant Sciences
ROIV
$24.3B
$2.21M ﹤0.01%
299,651
+250,670
+512% +$2.06M
PNST.WS
1378
CALL
DELISTED
Pinstripes Holdings, Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share
PNST.WS
$2.21M ﹤0.01%
212,499
VMGAW
1379
CALL
DELISTED
VMG Consumer Acquisition Corp. Warrant
VMGAW
$2.2M ﹤0.01%
212,499
MCY icon
1380
Mercury Insurance
MCY
$6.07B
$2.2M ﹤0.01%
+69,315
New +$2.36M
OBE
1381
Obsidian Energy
OBE
$628M
$2.2M ﹤0.01%
+343,503
New +$2.24M
PYPL icon
1382
PUT
PayPal
PYPL
$51.4B
$2.19M ﹤0.01%
28,900
-57,800
-67% -$4.45M
FXE icon
1383
PUT
Invesco CurrencyShares Euro Currency Trust
FXE
$342M
$2.19M ﹤0.01%
21,900
-42,800
-66% -$4.24M
LFST icon
1384
Lifestance Health
LFST
$4.29B
$2.19M ﹤0.01%
+295,108
New +$1.64M
TERN
1385
DELISTED
Terns Pharmaceuticals
TERN
$2.19M ﹤0.01%
185,028
+148,947
+413% +$1.42M
AFTR.WS
1386
CALL
DELISTED
AfterNext HealthTech Acquisition Corp Warrants
AFTR.WS
$2.18M ﹤0.01%
213,399
ACBAW
1387
CALL
DELISTED
Ace Global Business Acquisition Ltd Warrant
ACBAW
$2.18M ﹤0.01%
200,548
ERAS icon
1388
Erasca
ERAS
$6.3B
$2.18M ﹤0.01%
724,056
+449,520
+164% +$1.63M
BWCAW
1389
CALL
DELISTED
Blue Whale Acquisition Corp I Warrant
BWCAW
$2.18M ﹤0.01%
219,105
IVE icon
1390
iShares S&P 500 Value ETF
IVE
$49.6B
$2.18M ﹤0.01%
+14,335
New +$2.17M
UA icon
1391
Under Armour Class C
UA
$2.97B
$2.16M ﹤0.01%
252,801
-279,334
-52% -$2.57M
ENIC icon
1392
Enel Chile
ENIC
$6.05B
$2.15M ﹤0.01%
796,778
+266,218
+50% +$601K
OPEN icon
1393
Opendoor
OPEN
$3.8B
$2.15M ﹤0.01%
1,262,261
+1,140,800
+939% +$1.88M
ALLO icon
1394
Allogene Therapeutics
ALLO
$573M
$2.15M ﹤0.01%
+435,020
New +$2.79M
ROCC
1395
DELISTED
Ranger Oil Corporation Class A Common Stock
ROCC
$2.14M ﹤0.01%
52,494
+14,500
+38% +$594K
WAL icon
1396
Western Alliance Bancorporation
WAL
$9.13B
$2.13M ﹤0.01%
60,051
+26,113
+77% +$1.6M
MAQCW
1397
CALL
DELISTED
Maquia Capital Acquisition Corporation Warrant
MAQCW
$2.13M ﹤0.01%
200,000
CBAY
1398
DELISTED
Cymabay Therapeutics
CBAY
$2.12M ﹤0.01%
243,181
+161,401
+197% +$1.29M
CIR
1399
DELISTED
CIRCOR International, Inc
CIR
$2.12M ﹤0.01%
+68,000
New +$1.86M
LGVCW
1400
CALL
DELISTED
LAMF Global Ventures Corp. I Warrant
LGVCW
$2.11M ﹤0.01%
202,288

Similar funds

Marshall Wace's Q1 2023 Portfolio in Review

As of Q1 2023, Marshall Wace held 3,576 positions worth $47.1B, up 5.9% from $44.5B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Marshall Wace's Q1 2023 filing shows 705 new, 706 increased, 825 reduced and 988 closed positions. Its largest new stake was Madrigal Pharmaceuticals: 541,764 shares worth $131M. The largest sale was Cigna, an estimated $312M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Marshall Wace's largest Q1 2023 buy was Madrigal Pharmaceuticals: 541,764 shares worth $131M.
  • Marshall Wace added most to Walmart Inc in Q1 2023, an estimated $417M increase.
  • Marshall Wace's biggest Q1 2023 reduction was Cigna, cutting an estimated $312M.
  • Marshall Wace fully exited Merck in Q1 2023, selling an estimated $115M.
  • Marshall Wace's ten largest holdings make up 14% of its $47.1B portfolio in Q1 2023.
  • Marshall Wace opened 705 new positions and closed 988 in Q1 2023.
  • Marshall Wace's portfolio value rose 5.9% quarter-over-quarter to $47.1B.

Based on Marshall Wace's 13F filing for Q1 2023, filed 15 May 2023.